Pfizer loses $US21b on drug failure
Sydney Morning Herald - 2 hours ago
Shares of Pfizer Inc fell almost 11 percent on Monday, wiping out $US21.3 billion of market value, after the world's biggest drug maker unexpectedly halted development of its most important experimental medicine.
Whither Pfizer? Motley Fool
UPDATE 7-Pfizer shares plunge after cholesterol drug fails Reuters
MarketWatch - Independent - Guardian Unlimited - Times Online
all 1,202 news articles »
Market Rallies Despite Pfizer, Economic Uncertainty
Forbes - 3 hours ago
The stock market rallied on Monday, as the three major indexes moved higher despite lingering concerns regarding the interest rate policies of the Federal Reserve as well as Pfizer's decision to halt development of a once promising drug.
Stocks in US Rise on Financial, Technology Company Takeovers Bloomberg
Mellon and New York bank create giant with $16bn deal Independent
HedgeCo.net - Scotsman - New York Times - Monsters and Critics.com
all 964 news articles »
LSI Logic and Agere agree $4bn merger
MSNBC - 10 hours ago
By Daniel Pimlott in New York. LSI Logic Corporation, the consumer computer storage maker, has agreed to buy Agere Systems, the chipmaker that specialises in the telecoms and storage sectors, for $4bn or $22.81 a share.
LSI Logic buying Agere Systems for $4B Monsters and Critics.com
UPDATE 5-LSI Logic to buy Agere for $3.5 billion in stock Reuters
Computerworld - Smartmoney.com - Minneapolis Star Tribune (subscription) - TheStreet.com
all 312 news articles »
|
|
![]()
| |
![]()
|
